Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-03-06Clinical Trial Update: Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial [NA]
This document reports a cluster randomized trial evaluating an educational program to increase colorectal cancer screening. The trial status…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating the combination of celecoxib with fluorouracil and radiation therapy for stage II or stage III rectal cancer that c…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Flt3L in Treating Patients With Metastatic Colorectal Cancer [Phase 1]
This document reports the completion of a Phase 1 trial evaluating Flt3L in patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: RCT to Examine the Effects of Scanning [NA]
An RCT investigating the effects of a scanning intervention in cancer patients has completed, with indications including breast cancer and c…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Celecoxib in Treating Patients With Early-Stage Rectal Cancer [NA]
The clinical trial evaluating celecoxib for early-stage rectal cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in combination with FOLFOX6 or FOLFIRI as second-line treatment for colorectal cancer has been terminated…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer [Phase 2]
A Phase 2 study evaluating panitumumab in combination with chemotherapy as second-line treatment for colorectal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating combination chemotherapy with Bevacizumab in stage IV colorectal cancer; the study was terminated and result…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer [NA]
A clinical trial evaluating an anal sphincter prosthesis in patients undergoing surgery for anal or rectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine with oxaliplatin as second-line therapy for metastatic colorectal cancer; the study was terminated with…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 trial of a biological therapy in patients with metastatic cancer conducted by Duke University has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer [Phase 1, Phase 2]
Pfizer conducted a Phase 1/2 trial of bosutinib plus capecitabine in multiple solid tumors, including advanced breast cancer and pancreatic …
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial update evaluating Olimersen in combination with Irinotecan for metastatic or recurrent colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer [Phase 2]
Phase 2 trial evaluating the safety and efficacy of combining cetuximab with the FOLFOX4 regimen in colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients [Phase 3]
A Phase 3 trial evaluated bevacizumab alone or in combination with capecitabine and oxaliplatin as support therapy for metastatic colorectal…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. [Phase 2]
Phase II trial evaluated cetuximab with XELOX, followed by maintenance cetuximab plus capecitabine, as first-line treatment in elderly patie…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Phase 2]
Phase II study of Avastin + Erbitux + Irinotecan as second-line treatment for colorectal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC [Phase 2]
Phase 2 trial comparing sequencing of irinotecan/cetuximab and XELOX/cetuximab in metastatic colorectal cancer; the study status is terminat…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating a Rebeccamycin analog in patients with metastatic or locally recurrent colorectal cancer has completed. The …
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 [Phase 2]
Phase 2 trial evaluating a HER2-targeted monoclonal antibody in combination with chemotherapy for advanced colorectal cancer that overexpres…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia [Phase 2]
This Phase 2 study evaluated whether atorvastatin calcium, oligofructose-enriched inulin, or sulindac could prevent colorectal neoplasia in …
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors [Phase 2]
This update notes that a Phase 2 online survivorship workshop study sponsored by Stanford University has completed for cancer survivors, inc…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Curcumin Biomarkers [Phase 1]
This clinical trial update indicates a completed Phase 1 study evaluating curcumin biomarkers in colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan [Phase 2]
Phase 2 clinical trial update evaluating a combination chemotherapy regimen for metastatic colorectal cancer in patients who were previously…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer [NA]
Clinical trial update describing a diagnostic procedure for identifying patients with metastatic colorectal cancer; the study status is comp…